|
1
|
Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.
|
J Clin Oncol
|
2004
|
4.63
|
|
2
|
Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.
|
N Engl J Med
|
2013
|
4.49
|
|
3
|
Use of normal tissue complication probability models in the clinic.
|
Int J Radiat Oncol Biol Phys
|
2010
|
4.33
|
|
4
|
Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
|
J Clin Oncol
|
2007
|
3.08
|
|
5
|
Radiation dose-volume effects in the heart.
|
Int J Radiat Oncol Biol Phys
|
2010
|
2.66
|
|
6
|
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.
|
Int J Radiat Oncol Biol Phys
|
2010
|
2.32
|
|
7
|
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer.
|
Ann Intern Med
|
2010
|
2.17
|
|
8
|
Radiation-associated cardiovascular disease.
|
Crit Rev Oncol Hematol
|
2003
|
1.97
|
|
9
|
Testicular cancer survivorship: research strategies and recommendations.
|
J Natl Cancer Inst
|
2010
|
1.76
|
|
10
|
A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.
|
Blood
|
2009
|
1.74
|
|
11
|
Radiation-related heart disease: current knowledge and future prospects.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.72
|
|
12
|
Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.
|
J Clin Oncol
|
2012
|
1.67
|
|
13
|
Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association.
|
Circulation
|
2013
|
1.67
|
|
14
|
The lessons of QUANTEC: recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.65
|
|
15
|
Second malignant neoplasms and cardiovascular disease following radiotherapy.
|
J Natl Cancer Inst
|
2012
|
1.64
|
|
16
|
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
|
Pediatr Blood Cancer
|
2012
|
1.49
|
|
17
|
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.44
|
|
18
|
Exercise capacity in long-term survivors of pediatric cancer: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.
|
Pediatr Blood Cancer
|
2012
|
1.43
|
|
19
|
Radiation-associated cardiovascular disease: manifestations and management.
|
Semin Radiat Oncol
|
2003
|
1.35
|
|
20
|
Normal tissue toxicity after small field hypofractionated stereotactic body radiation.
|
Radiat Oncol
|
2008
|
1.21
|
|
21
|
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort study.
|
Ann Intern Med
|
2012
|
1.20
|
|
22
|
Neurocognitive function after radiotherapy for paediatric brain tumours.
|
Nat Rev Neurol
|
2012
|
1.19
|
|
23
|
Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.16
|
|
24
|
Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge?
|
Semin Radiat Oncol
|
2006
|
1.13
|
|
25
|
Long-term effects of treatments for childhood cancers.
|
Curr Opin Pediatr
|
2007
|
1.12
|
|
26
|
Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.
|
J Clin Oncol
|
2012
|
1.12
|
|
27
|
Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.
|
Semin Radiat Oncol
|
2007
|
1.10
|
|
28
|
Normal tissue tolerance dose metrics for radiation therapy of major organs.
|
Semin Radiat Oncol
|
2007
|
1.06
|
|
29
|
Bone density changes after radiation for extremity sarcomas: exploring the etiology of pathologic fractures.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.01
|
|
30
|
Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort.
|
Radiat Res
|
2010
|
1.01
|
|
31
|
Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
|
Lancet Oncol
|
2013
|
1.01
|
|
32
|
Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications.
|
J Clin Oncol
|
2013
|
0.96
|
|
33
|
Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study.
|
J Clin Oncol
|
2010
|
0.96
|
|
34
|
Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.94
|
|
35
|
Late morbidity after successful treatment of children with cancer.
|
Cancer J
|
2009
|
0.93
|
|
36
|
Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
|
J Clin Oncol
|
2011
|
0.93
|
|
37
|
Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.92
|
|
38
|
Normal tissue development, homeostasis, senescence, and the sensitivity to radiation injury across the age spectrum.
|
Semin Radiat Oncol
|
2010
|
0.91
|
|
39
|
Characteristics and determinants of adiposity in pediatric cancer survivors.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.90
|
|
40
|
A systematic review of dental late effects in survivors of childhood cancer.
|
Pediatr Blood Cancer
|
2013
|
0.90
|
|
41
|
Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study.
|
Am Heart J
|
2012
|
0.89
|
|
42
|
Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Oncol Biol Phys 2009;73:492-498).
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.89
|
|
43
|
Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: a population-based study of 28,844 patients.
|
Cancer
|
2014
|
0.88
|
|
44
|
Patterns and timing of initial relapse in patients subsequently undergoing transplantation for Hodgkin's lymphoma.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.87
|
|
45
|
Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.
|
Semin Radiat Oncol
|
2010
|
0.87
|
|
46
|
Survival after second primary lung cancer: a population-based study of 187 Hodgkin lymphoma patients.
|
Cancer
|
2011
|
0.86
|
|
47
|
Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.
|
Clin Cancer Res
|
2009
|
0.86
|
|
48
|
Late effects of treatment for Hodgkin lymphoma.
|
J Natl Compr Canc Netw
|
2006
|
0.86
|
|
49
|
Dietary quality, caloric intake, and adiposity of childhood cancer survivors and their siblings: an analysis from the cardiac risk factors in childhood cancer survivors study.
|
Nutr Cancer
|
2013
|
0.85
|
|
50
|
ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
|
J Am Coll Radiol
|
2008
|
0.83
|
|
51
|
Second malignant neoplasms and cardiovascular disease following radiotherapy.
|
Health Phys
|
2014
|
0.83
|
|
52
|
Role of pentoxifylline in preventing radiation damage to epiphyseal growth plate chondrocytes.
|
Radiat Res
|
2002
|
0.83
|
|
53
|
Pleural effusions in patients with Hodgkin lymphoma: clinical predictors and associations with outcome.
|
Leuk Lymphoma
|
2014
|
0.82
|
|
54
|
A clinic-based, comprehensive care model for studying late effects in long-term survivors of pediatric illnesses.
|
Pediatrics
|
2004
|
0.81
|
|
55
|
Cancer genesis across the age spectrum: associations with tissue development, maintenance, and senescence.
|
Semin Radiat Oncol
|
2010
|
0.81
|
|
56
|
ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma.
|
Pediatr Blood Cancer
|
2014
|
0.80
|
|
57
|
Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population.
|
Pediatr Blood Cancer
|
2014
|
0.79
|
|
58
|
A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.
|
Biol Blood Marrow Transplant
|
2010
|
0.79
|
|
59
|
Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma.
|
Radiother Oncol
|
2012
|
0.79
|
|
60
|
ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma.
|
Curr Probl Cancer
|
2010
|
0.79
|
|
61
|
Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.78
|
|
62
|
Cranial irradiation as an additional risk factor for anthracycline cardiotoxicity in childhood cancer survivors: an analysis from the cardiac risk factors in childhood cancer survivors study.
|
Pediatr Cardiol
|
2012
|
0.78
|
|
63
|
Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.
|
Cancer
|
2015
|
0.78
|
|
64
|
Ninth Annual Warren K. Sinclair Keynote Address: effects of childhood radiation exposure: an issue from computed tomography scans to Fukushima.
|
Health Phys
|
2013
|
0.77
|
|
65
|
ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II.
|
Am J Clin Oncol
|
2016
|
0.77
|
|
66
|
ACR Appropriateness Criteria® on Hodgkin's lymphoma-unfavorable clinical stage I and II.
|
J Am Coll Radiol
|
2011
|
0.76
|
|
67
|
Incidental brain lesions in children: to treat or not to treat?
|
J Neurooncol
|
2011
|
0.76
|
|
68
|
A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation.
|
Biol Blood Marrow Transplant
|
2013
|
0.76
|
|
69
|
Do children with optic pathway tumors have an increased frequency of other central nervous system tumors?
|
Neuro Oncol
|
2003
|
0.76
|
|
70
|
ACR Appropriateness Criteria: Localized nodal indolent lymphoma.
|
Oncology (Williston Park)
|
2013
|
0.76
|
|
71
|
Protons, the brainstem, and toxicity: ingredients for an emerging dialectic.
|
Acta Oncol
|
2014
|
0.75
|
|
72
|
Variables affecting survival after second primary lung cancer: A population-based study of 187 Hodgkin's lymphoma patients.
|
J Thorac Dis
|
2012
|
0.75
|
|
73
|
A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.
|
Curr Pediatr Rev
|
2014
|
0.75
|
|
74
|
Late effects of therapy for Hodgkin's lymphoma.
|
Curr Hematol Malig Rep
|
2007
|
0.75
|
|
75
|
ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.
|
Am J Clin Oncol
|
2016
|
0.75
|
|
76
|
Five tumors over six years in eighth decade of life.
|
Cancer Invest
|
2008
|
0.75
|
|
77
|
Spurious progression in pediatric brain tumors.
|
J Neurooncol
|
2012
|
0.75
|
|
78
|
The integration of cancer survivorship training in the curriculum of hematology/oncology fellows and radiation oncology residents.
|
J Cancer Surviv
|
2013
|
0.75
|
|
79
|
ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma.
|
Am J Clin Oncol
|
2015
|
0.75
|
|
80
|
Introduction: The ageless quest to understand aging, but with a malignant twist.
|
Semin Radiat Oncol
|
2010
|
0.75
|
|
81
|
Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
|
Cancer Invest
|
2008
|
0.75
|
|
82
|
Involved field radiation after autologous stem cell transplant for diffuse large B-cell lymphoma in the rituximab era.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.75
|
|
83
|
ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma.
|
Oncology (Williston Park)
|
2016
|
0.75
|